Browse the latest stories and reports on MSF from various media outlets.

August 15, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) nurse and researcher, Chenai Mathabire, received the International Aids Society 2017 TB/HIV Research Prize for research on a rapid tuberculosis (TB) test. View External Media.

August 01, 2017

Following the International AIDS conference, UNAIDS released a report that indicates more than half of the 36.7 million people with HIV have access to treatment for the first time. Despite this encouraging statistic, both HIV and AIDS death rates are increasing in Central Asia and Eastern Europe. NPR spoke with Doctors Without Borders/Médecins Sans Frontières (MSF) HIV and TB policy adviser, Sharonann Lynch, about the most recent HIV/AIDS trends. 

July 18, 2016

A new effort focuses on preventing the spread of HIV along a much-traveled highway in Mozambique. View external media.

December 01, 2015

Diana Johnson shares stories and drawings from her assignment as a nurse in an HIV program in Zemio, Central African Republic. View external media.

July 26, 2013

MSF is raising concerns about trade negotiations that could prevent India from manufacturing affordable, generic versions of newer AIDS medications.

July 16, 2013

New WHO guidelines for HIV treatment are a major step forward, but they will be a challenge for countries such as South Africa to implement, according to MSF's Dr. Gilles van Cutsem. 

June 28, 2013

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

June 25, 2013

South Africa has made major progress in the fight against AIDS since 2001, when MSF was the only organization providing antiretroviral treatment in the country. "Adherence clubs" piloted by MSF now make treatment more accessible than ever.

October 11, 2012

Access to medicines is a crucial issue in private talks over the Trans-Pacific Partnership, the largest trade deal in U.S. history.

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

Pages